Type 1 Diabetes in Pregnancy Doubles Risk for Autism in Offspring Type 1 Diabetes in Pregnancy Doubles Risk for Autism in Offspring
Risk of autism more than doubles in children born to mothers with type 1 diabetes and is greater than the risk of the condition when mum has type 2 diabetes or gestational diabetes.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 25, 2018 Category: Dermatology Tags: Diabetes & Endocrinology News Source Type: news

FDA Approves Adjuvant Combo for BRAF+ Melanoma FDA Approves Adjuvant Combo for BRAF+ Melanoma
The two targeted therapies, dabrafenib and trametinib, are already approved in combination in the metastatic setting.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 1, 2018 Category: Dermatology Tags: Hematology-Oncology News Alert Source Type: news

Yoga Face-toning Might Compete With Fillers and Facelifts Yoga Face-toning Might Compete With Fillers and Facelifts
To his toolbox of Botox, fillers and plastic surgery, cosmetic dermatologist Dr. Murad Alam has added a new, low-cost, noninvasive anti-aging treatment: facial yoga.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 17, 2018 Category: Dermatology Tags: Dermatology News Source Type: news

Dermatology Guideline Authors Take Big Payments From Industry Dermatology Guideline Authors Take Big Payments From Industry
Dermatology clinical practice guideline authors often receive large payments from industry and don't always fully disclose them, researchers report.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 26, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

Delafloxacin an Effective Option for Acute Bacterial Skin Infections Delafloxacin an Effective Option for Acute Bacterial Skin Infections
Delafloxacin is non-inferior to vancomycin plus aztreonam for treating acute bacterial skin and skin-structure infections (ABSSSI), according to a new phase 3 trial.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 16, 2017 Category: Dermatology Tags: Infectious Diseases News Source Type: news

Propranolol May Delay Progression of Cutaneous Melanoma Propranolol May Delay Progression of Cutaneous Melanoma
Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 4, 2017 Category: Dermatology Tags: Hematology-Oncology News Source Type: news

How Safe Are Various Systemic Therapies for Pediatric Psoriasis? How Safe Are Various Systemic Therapies for Pediatric Psoriasis?
Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 27, 2017 Category: Dermatology Tags: Pediatrics News Source Type: news

Cosentyx Highly Effective in Scalp Psoriasis Cosentyx Highly Effective in Scalp Psoriasis
Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 15, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

EU Clears Brodalumab (Kyntheum) for Plaque Psoriasis EU Clears Brodalumab (Kyntheum) for Plaque Psoriasis
Brodalumab is for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.International Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 21, 2017 Category: Dermatology Tags: Dermatology News Alert Source Type: news

A Promising New Treatment for Vitiligo? A Promising New Treatment for Vitiligo?
Dr Graeme Lipper reviews a proof-of-concept study of a JAK inhibitor that holds potential for the treatment of vitiligo.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 12, 2017 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news

Ixekizumab Eases Psoriatic Arthritis When TNF Inhibitor Fails Ixekizumab Eases Psoriatic Arthritis When TNF Inhibitor Fails
The selective interleukin-17A inhibitor ixekizumab improved signs and symptoms of active psoriatic arthritis (PsA) in patients who had failed prior biologic therapy in the phase 3 SPIRIT-P2 trial.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 2, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

A Side-by-Side Look at the Most Common Rosacea Treatments A Side-by-Side Look at the Most Common Rosacea Treatments
A quick comparison of the most common treatments for rosacea.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 17, 2017 Category: Dermatology Tags: Dermatology Article Source Type: news

Skin Lightening Under Fire as Indians Seek Whiter Shade of Pale Skin Lightening Under Fire as Indians Seek Whiter Shade of Pale
Mirror, mirror on the wall - who is the fairest of them all? The one with the palest skin, of course.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 1, 2017 Category: Dermatology Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news

CHMP Recommends Skilarence for Psoriasis CHMP Recommends Skilarence for Psoriasis
The Committee for Medicinal Products for Human Use of the European Medicines Agency recommended granting marketing approval for Skilarence for treatment of psoriasis.International Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 21, 2017 Category: Dermatology Tags: Dermatology News Alert Source Type: news

FDA Clears Second Remicade Biosimilar (Renflexis) FDA Clears Second Remicade Biosimilar (Renflexis)
The FDA approves infliximab-abda (Renflexis, Samsung Bioepis) for multiple indications.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 21, 2017 Category: Dermatology Tags: Rheumatology News Alert Source Type: news

Sunscreen or Sun Screen? Sunscreen or Sun Screen?
In light of myths and concerns about sunscreen, Dr Lipper reviews whether natural alternatives are effective.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 21, 2017 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news

Are We Overtreating Severely Dysplastic Nevi? Are We Overtreating Severely Dysplastic Nevi?
Even with negative margins, most severely dysplastic nevi are re-excised. Is this necessary or overtreatment?Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 21, 2017 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news

How Should Physicians Respond to Latest Alopecia Research? How Should Physicians Respond to Latest Alopecia Research?
Dr Lipper discusses evidence and strategy for treating patients with alopecia areata.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 17, 2017 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news

Dermoscopy Can Help Distinguish Melanoma From Benign Skin Lesions Dermoscopy Can Help Distinguish Melanoma From Benign Skin Lesions
Dermoscopy can help identify seborrheic keratosis (SK)-like melanomas that are challenging to detect otherwise, researchers say.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 11, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

Movie Villains With Scars May Haunt Those With Skin Conditions Movie Villains With Scars May Haunt Those With Skin Conditions
The scars and facial features of some of cinema's most terrifying villains may end up haunting people who share those traits, suggests a new study.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 10, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

Pretty Baby: Propranolol for Noncritical IH? Pretty Baby: Propranolol for Noncritical IH?
Dr Graeme Lipper reviews an important study on infantile hemangiomas and discusses a potential new protocol for noncritical cases.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 5, 2017 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news

Fingernail Psoriasis Data Added to Humira Prescribing Info Fingernail Psoriasis Data Added to Humira Prescribing Info
The FDA has approved the addition of moderate to severe fingernail psoriasis data to the Humira prescribing information for those with moderate to severe chronic plaque psoriasis.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 30, 2017 Category: Dermatology Tags: Dermatology News Alert Source Type: news

Foamix's Acne Drug Misses Main Goal in Key Study Foamix's Acne Drug Misses Main Goal in Key Study
Foamix Pharmaceuticals Ltd said on Monday its experimental acne treatment failed to meet one of two main goals in a late-stage study.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 28, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

FDA Approves Dupilumab (Dupixent) for Eczema FDA Approves Dupilumab (Dupixent) for Eczema
Designated a breakthrough therapy, dupilumab spares patients with moderate to severe eczema from the need to resort to systemic immunosuppressants and the higher risks they pose.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 28, 2017 Category: Dermatology Tags: Dermatology News Alert Source Type: news

New Topical for Mild to Moderate Psoriasis in the Works New Topical for Mild to Moderate Psoriasis in the Works
It's been decades since a new topical option has been available for mild-to-moderate psoriasis, but a new agent shows promise in a phase 3 trial presented as a late-breaker at the AAD Annual Meeting.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 5, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

Mnenomic to Cut False Diagnoses of Recluse Spider Bites Mnenomic to Cut False Diagnoses of Recluse Spider Bites
A simple mnemonic can help avoid false diagnosis of recluse spider bites, which has been mistaken for up to 40 other medical conditions, according to three U.S. researchers.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 24, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

Arthritis Drugs Get Nod From EMA's CHMP Arthritis Drugs Get Nod From EMA's CHMP
Tofacitinib citrate (Xeljanz), two adalimumab (Humira) biosimilars, and one methotrexate hybrid get thumbs up from EMA committee.International Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 27, 2017 Category: Dermatology Tags: Rheumatology News Alert Source Type: news

Decision to Treat Actinic Keratosis Depends on How Physicians Frame Risks Decision to Treat Actinic Keratosis Depends on How Physicians Frame Risks
Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 26, 2017 Category: Dermatology Tags: Hematology-Oncology News Source Type: news

FDA OKs New Cream for Facial Erythema in Rosacea in Adults FDA OKs New Cream for Facial Erythema in Rosacea in Adults
Oxymetazoline hydrochloride 1% cream (Rhofade, Allergan) is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 19, 2017 Category: Dermatology Tags: Dermatology News Alert Source Type: news

CHMP Backs Baricitinib, Lifmior for Rheumatoid Arthritis CHMP Backs Baricitinib, Lifmior for Rheumatoid Arthritis
The EMA's CHMP recommended baricitinib for rheumatoid arthritis and Lifmior for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis.International Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 16, 2016 Category: Dermatology Tags: Rheumatology News Alert Source Type: news

FDA Clears Two New Dermal Fillers for Laugh Lines FDA Clears Two New Dermal Fillers for Laugh Lines
Restylane Refyne and Restylane Defyne use next-generation technology, which creates a smooth, injectable gel that provides more natural-looking results, the company says.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 12, 2016 Category: Dermatology Tags: Dermatology News Alert Source Type: news

ED Visits for Severe Sunburn Rack Up Millions in Costs ED Visits for Severe Sunburn Rack Up Millions in Costs
Although sunburns are highly preventable, they are still responsible for tens of thousands of expensive visits to U.S. emergency departments each year, according to a recent analysis.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 9, 2016 Category: Dermatology Tags: Dermatology News Source Type: news

Sirolimus Gel for Tuberous Sclerosis Facial Angiofibromas Sirolimus Gel for Tuberous Sclerosis Facial Angiofibromas
A topical sirolimus gel is safe and effective for treating facial angiofibromas in patients with tuberous sclerosis complex (TSC), Japanese researchers report.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 23, 2016 Category: Dermatology Tags: Hematology-Oncology News Source Type: news

Psoriasis and Migraine: What's the Connection? Psoriasis and Migraine: What's the Connection?
A disease severity-dependent increased risk for migraine in psoriasis and increased risk for new-onset migraine in psoriatic arthritis could be mediated by the usual suspects — proinflammatory cytokines.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 17, 2016 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news

Could Treating Psoriasis Slow CAD Progression? Could Treating Psoriasis Slow CAD Progression?
Dr Lipper summarizes a new study that included adults with severe psoriasis who were treated with biologics.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 17, 2016 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news

FDA OKs Etanercept (Enbrel) for Kids With Plaque Psoriasis FDA OKs Etanercept (Enbrel) for Kids With Plaque Psoriasis
Etanercept becomes the first biologic approved for children aged 4 years and older with moderate-to-severe plaque psoriasis.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 8, 2016 Category: Dermatology Tags: Dermatology News Alert Source Type: news

Abametapir Kills Lice and Eggs in Phase 3 Trials Abametapir Kills Lice and Eggs in Phase 3 Trials
An experimental treatment kills head lice after only one application and, unlike currently available treatments, also kills their eggs, according to new research.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 2, 2016 Category: Dermatology Tags: Pediatrics News Source Type: news

Post-Finasteride Syndrome Not Related to Androgen Deficiency Post-Finasteride Syndrome Not Related to Androgen Deficiency
Men who report persistent sexual symptoms after using finasteride for hair loss do not show abnormalities in androgens or their receptors, according to a new report.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 27, 2016 Category: Dermatology Tags: Diabetes & Endocrinology News Source Type: news

Prolonged Survival With Adjuvant Ipilimumab in Stage 3 Melanoma Prolonged Survival With Adjuvant Ipilimumab in Stage 3 Melanoma
New results show that adjuvant ipilimumab improves survival, but the drug was used at a higher dose of 10 mg/kg and had serious side effects.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 10, 2016 Category: Dermatology Tags: Hematology-Oncology News Source Type: news

Most U.S. Dermatologists Receive Industry Money Most U.S. Dermatologists Receive Industry Money
Nearly three-quarters of U.S. dermatologists received payments worth a collective $34 million from drug companies in 2014, according to a new analysis of a public database.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 7, 2016 Category: Dermatology Tags: Dermatology News Source Type: news

Ixekizumab Effective in Phase 3 Psoriatic Arthritis Trial Ixekizumab Effective in Phase 3 Psoriatic Arthritis Trial
Ixekizumab, a monoclonal antibody that inhibits interleukin 17A, was safe and effective for treating psoriatic arthritis in patients not previously treated with biologics.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 9, 2016 Category: Dermatology Tags: Rheumatology News Source Type: news

Does Dairy Cause Acne? Does Dairy Cause Acne?
Dr Graeme Lipper reviews a large case-control study that examined the link between acne and milk consumption in teenagers.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 2, 2016 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news

Atherosclerosis Risk: Psoriasis Stronger Predictor Than Diabetes Atherosclerosis Risk: Psoriasis Stronger Predictor Than Diabetes
Associations between atherosclerosis risk and type 2 diabetes appear primarily driven by weight, whereas risk with psoriasis is independent of known cardiometabolic risk factors.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 25, 2016 Category: Dermatology Tags: Dermatology News Source Type: news

Hemangioma Characteristics Predict Outcome in Infants Hemangioma Characteristics Predict Outcome in Infants
Following natural involution, combined hemangiomas are among those more likely to leave sequelae in infants, according to a retrospective photographic review.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 24, 2016 Category: Dermatology Tags: Pediatrics News Source Type: news

Fingernail Removal of Seborrheic Keratoses Fingernail Removal of Seborrheic Keratoses
Dr Lundberg describes his unique method for excising SK and reports no complications at 10 and 25 years.Medscape Internal Medicine (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 10, 2016 Category: Dermatology Tags: Internal Medicine Commentary Source Type: news

Melanoma Less Common But More Deadly for Black Patients Melanoma Less Common But More Deadly for Black Patients
Even though Caucasians are much more likely to develop melanoma than other ethnic groups, people of color who do get the disease are less likely to survive, a U.S. study suggests.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 5, 2016 Category: Dermatology Tags: Hematology-Oncology News Source Type: news

Which Psoriasis Biologics Have the Best Response Rates? Which Psoriasis Biologics Have the Best Response Rates?
Dr Graeme Lipper reviews a retrospective observational study that sought to find out how long patients stayed on a biologic drug they were taking to treat psoriasis.Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 4, 2016 Category: Dermatology Tags: Dermatology Viewpoint Source Type: news

A 78-Year-Old Tennis Player With a Growth on His ScalpA 78-Year-Old Tennis Player With a Growth on His Scalp
A 78-year-old man with Fitzpatrick skin type I presents with a growth on his scalp. What's your diagnosis? Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 20, 2016 Category: Dermatology Tags: Dermatology Case Challenge Source Type: news

A 78-Year-Old Tennis Player With a Growth on His Scalp A 78-Year-Old Tennis Player With a Growth on His Scalp
A 78-year-old man with Fitzpatrick skin type I presents with a growth on his scalp. What's your diagnosis? Medscape Dermatology (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 20, 2016 Category: Dermatology Tags: Dermatology Case Challenge Source Type: news

Valeant Psoriasis Drug's Suicide Risk Hard to Assess -FDA StaffValeant Psoriasis Drug's Suicide Risk Hard to Assess -FDA Staff
Valeant Pharmaceuticals International Inc's experimental drug to treat psoriasis carries a potential risk of suicide that is challenging to assess due to limited data, a preliminary review by the U.S. Food and Drug Administration said on Friday. Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 19, 2016 Category: Dermatology Tags: Pharmacist News Source Type: news